Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Key Takeaways Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies. A jury in October found the companies not liable in a case alleging their infant formula products caused necrotizing enterocolitis, a disease of the bowels. Abbott and Reckitt both